Connect with us


Hoymiles Shines at RE+ with New Hybrid Inverter Launched in the US



PLANO, Texas, Sept. 18, 2023 /PRNewswire/ — Hoymiles made a truly memorable impact at this year’s RE+ solar expo held in the US from September 12 to 14. At this top PV industry expo in the US, Hoymiles launched the HYS-LV-USG1 series of single-phase microinverters in response to the increasing demand for energy storage, which was widely applauded by visitors and industry insiders.

New Hybrid Inverter to Upgrade Energy Independence

Following the official launch of the next-gen hybrid inverters in the US on September 11, Hoymiles presented the models for the first time at the RE+ expo. This is the US version of Hoymiles energy storage solution after it released the series in Europe in 2022.

The HYS series of hybrid inverters can work both on-grid and off-grid, enabling an always-on energy ecosystem for homeowners. When paired with batteries and generators, they will offer uninterrupted solar power backup to homeowners, saving more electricity costs and promising greater energy independence.

Power options of HYS-LV-USG1:







3.8 kW

4.8 kW

6.0 kW

7.6 kW

9.6 kW

11.5 kW

More about the core advantages of HYS-LV-USG1:

Supports 120 V/240 V backup power without external autotransformerOffers an industry-leading DC/AC ratio of up to 150%Ensures Seamless backup power for home or critical loadsEquipped with integrated arc fault protection and rapid shutdown functionThe intelligent EMS function supports self-consumption mode, economic mode, and backup mode for multi-scenario applications

Special sharing sessions were also held during the expo to guide visitors through the highlights and capabilities of the new hybrid inverters.

Tech and product sharing to deepen connections

During the expo event, Hoymiles also hosted a series of in-depth presentations given by our experienced technical support experts to illustrate Hoymiles solutions including microinverters, gateway DTUs, remote monitoring platform S-Miles Cloud, and rapid shutdown devices. Visitors were able to explore the intricacies of our technology and how the products blend into the Hoymiles ecosystem.

Leadership insights in the spotlight

During the expo, Hoymiles invited industry experts to share their insights with participants. In particular, NABCEP’s CEO Shawn O’Brien gave a presentation on the topic “Workforce and Professional Development Initiative”, and Energysage’s Director of Insight Spencer Fields gave a speech on the topic “Shining a Light on Progress: A Glimpse into the US Residential Solar and Energy Storage Market Trends in 2023”. The presentations were highly appreciated and well-received by the audience.

At the sidelines of the event, Hoymiles Marketing Director Sandra and Hoymiles USA CEO Rocky received an interview from our partner EnergySage. They discussed the developments and advantages of the company and shared the progress of the local services in North America“. Hoymiles also attended the first U.S. Installer Awards co-hosted by EUPD Research and RE+ as one of the three sponsors, witnessing the pinnacle moments of excellent installers. Following the end of the expo, EUPD scheduled an exclusive interview with Rocky to discuss the company’s development and provide an overview of its technological strengths. Rocky explained the competitive edge of Hoymiles’ products and outlined the company’s future plan in the US.

The RE+ expo was an inspiring mix of ideas, collaborations, and interactions. The Hoymiles team extends our sincere gratitude to the attendees who visited our booth and contributed to the fruitful discussions about our solar solutions and technologies. See you next year!

Contact details of Hoymiles USA
Address: 3001 Technology Drive, Suite 100, Plano, TX 75074
Tel: (972) 798-2831


View original content to download multimedia:

SOURCE Hoymiles Power Electronic Inc. USA

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Science and Technology Daily: Global Talents Enjoy the Honor of China




BEIJING, June 23, 2024 /PRNewswire/ — It’s a tremendous honor to receive the China International Science and Technology Cooperation Award. We pay high tribute to those honorees who have made important contributions to scientific and technological advancements. Let’s look forward to seeing who will be awarded this honor this year.

View original content to download multimedia:

SOURCE Science and Technology Daily

Continue Reading


Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa




SINGAPORE, June 23, 2024 /PRNewswire/ — Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, has been granted distribution rights for Caris Life Sciences (Caris)’ solid tumour molecular profiling services in the Middle East and Africa (MEA). Caris is the leading next-generation AI TechBio company and precision medicine pioneer. This expansion follows the initial January 2023 distribution rights partnership with Caris for the same services in Southeast Asia (SEA). Juniper is now poised to offer Caris’ advanced solid tumour molecular profiling services across a broader region, enhancing patient access to personalised treatment options.

Caris’ best-in-class molecular profiling, combined with proprietary artificial intelligence, provides more precise and individualized cancer treatments. This profiling approach assesses DNA, RNA, and proteins, revealing a molecular blueprint that identifies treatment options specific to each patient’s cancer. Caris has developed the world’s largest and most informative platform for cancer analysis, featuring the most advanced tumour profiling available, including Whole Exome and Whole Transcriptome Sequencing across over 23,000 genes. By analysing biomarkers found in tumours, Caris helps healthcare providers make informed choices for personalised care.

Juniper Biologics is committed to driving positive change in the pharmaceutical industry on a global scale. Aligned with its mission to deliver transformative therapies through bold scientific innovation, Juniper’s collaboration with Caris will enhance access to quality treatments for patient communities in the Middle East and Africa. Juniper continues to pursue impactful partnerships aimed at uplifting communities and individuals, especially in underserved regions where access to advanced therapies is limited.

Raman Singh, Founder and Chief Executive Officer (CEO) of Juniper Biologics, spoke on the successful acquisition: “Caris molecular profiling bridges the gap between tumour biology and cancer treatments, guiding precision medicine through personalised treatment selection for physicians and their patients. Our exclusive partnership with Caris Life Sciences to distribute this service in the Middle East and Africa will significantly empower healthcare professionals to make informed decisions for their patients. This service enables oncologists to recommend highly personalised treatments that specifically target a patient’s cancer, thereby improving and expanding their care options. This targeted approach offers patients, particularly those with rare or aggressive cancers, an improved quality of life.”

“Caris is pleased to expand the distribution of our molecular profiling services in the Middle East and Africa through our partnership with Juniper Biologics,” said Caris President David Spetzler, MS, PhD, MBA. “This collaboration aligns with Caris’ goal of enabling clinicians worldwide to make the best individualised treatment choices for their patients and ultimately helping to improve patient outcomes.”

This partnership marks a significant milestone in expanding access to personalised medicine and advanced cancer treatment technologies in the Middle East and Africa.

About Juniper Biologics

Backed by The Sylvan Group, Juniper Biologics is a science-led healthcare company focused on delivering novel therapies to improve the health and quality of life of patients, by building a growing presence in Oncology and Oncology Supportive Care, Rare/Orphan Diseases and Gene Therapy. It was founded on a vision to provide treatments for unmet medical needs focused on specialist therapy areas in which it can make the most difference. Through bold and transformative science, Juniper Biologics is committed to creating possibilities that have the potential to become the next generation of life-changing medicines for patient communities in China, Japan, Asia, Australia, New Zealand, Middle East, and Africa.



About Caris Life Sciences
Caris Life Sciences® (Caris) is the leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms, Caris has created the large-scale, multi-modal database and computing capability needed to analyse and unravel the molecular complexity of disease. This convergence of sequencing power, big data, and AI technologies provides an unmatched platform to deliver the next generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection, and drug development.

Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia, and other international markets. To learn more, please visit


View original content:

Continue Reading


Rīgas Satiksme (Riga municipality public transportation) achieves significant cost and carbon savings with Papercast e-paper




Rīgas Satiksme is further enhancing the travel experience for Riga’s Public transport users with the second phase rollout of Papercast® sustainable, low power e-paper displays. This initiative underscores Rīgas municipality owned Public transportation company shift from traditional, power-hungry LED displays to more sustainable technologies.

LONDON and RIGA, Latvia, June 23, 2024 /PRNewswire-PRWeb/ — Rīgas Satiksme is further enhancing the travel experience for Riga’s Public transport users with the second phase rollout of Papercast® sustainable, low power e-paper displays. This initiative underscores Rīgas municipality owned Public transportation company shift from traditional, power-hungry LED displays to more sustainable technologies.

“We are thrilled to continue our partnership with Rīgas Satiksme in their mission to embrace cutting edge, sustainable passenger information solutions,” said Cameron Maconie, Head of Business Development at Papercast.

Driven by the success of its initial deployment and buoyed by positive feedback from passengers, Rīgas Satiksme is extending its digitalization of public transport stops network with Papercast’s 23″ e-paper displays. Following a rigorous evaluation process, Rīgas selected Papercast for this second phase expansion, highlighting the calibre and sustainability of its technology.

Maximising cost and carbon savings

Offering one of the most sustainable digital bus stop solutions available, the Papercast displays supplied to Rīgas Satiksme recharge overnight using streetlight power, ensuring minimal energy consumption and high functionality. This setup enables significant cost and carbon savings:

Papercast e-paper displays use only 15 Wh per day, compared to 1,080 Wh for LED displays—a remarkable 98.6% reduction.This translates to an annual cost of €1.53 per display for Papercast, compared to €1,080 for LED.Papercast’s displays emit just 1 kg carbon annually compared to 82 kg for LED—a 98.8% decrease.

These savings are crucial for Rīgas Satiksme as they move towards more sustainable public transport solutions as add on to the new Electrical bus fleet and Trams lines extension .

Retrofitting for efficiency

The decision to expand the network with Papercast’s e-paper displays is rooted in their stability, excellent outdoor visibility, user-friendly interface, low power consumption, ease of installation and customisable features. By retrofitting the displays onto Rīgas’ Satiksme existing infrastructure, deployment time and costs are minimised, including integration with new fleet management system.

Enhanced passenger experience

The 23″ e-paper displays provide real-time information at digital stops and shelters for trams, buses and trolleybus services. The content management system (CMS) allows for effortless control over content dissemination and device management, enhancing the overall proposition.

“We are thrilled to continue our partnership with Rīgas Satiksme in their mission to embrace cutting edge, sustainable passenger information solutions,” said Cameron Maconie, Head of Business Development at Papercast. “The selection of Papercast displays for the second phase rollout underscores the unmatched benefits of our market leading technology, making it the ideal choice for modernising public transport infrastructure.”

Using E Ink technology, Papercast e-paper bus stop displays are well proven around the world with deployments in more than 45 countries.


Papercast’s range of solar powered, wireless e-paper bus stop displays provide excellent visibility, even in direct sunlight, and have been engineered with leading design principles of superior functionality and exceptionally low energy consumption. Completely stand-alone, the displays can be easily installed ‘off-the-grid’ within hours and the cloud-based data management platform provides complete control and real-time data integration.

Share this story and follow Papercast on Twitter, LinkedIn, Facebook and YouTube


Kerry Marchbank

Marketing Manager

+44 (0)7817 916654

Media Contact

Kerry Marchbank, Papercast Ltd, 44 02070431355,,

View original content to download multimedia:

SOURCE Papercast Ltd

Continue Reading